Affiliation:
1. Chemistry Process R&D Idorsia Pharmaceuticals Ltd. CH-4123 Allschwil Switzerland
Abstract
Abstract2‐(3‐Bromophenyl)‐2H‐1,2,3‐triazole is a low molecular‐weight building block that is not readily accessible in pure form by standard synthetic approaches due to competing formation of the triazol‐1‐yl regioisomer. After investigation of a wide range of synthetic routes, a process based on construction of the triazole heterocycle by cyclization of an activated dihydrazone was developed. A suitable isolation method had to be identified before embarking on a demonstration run on >100 g scale without the need for chromatography. The new process delivered the desired building block in 48 % overall yield over four telescoped steps with excellent purity (99 % a/a).
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Biochemistry,Catalysis
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献